Researchers conducted a retrospective and prospective observational study to assess the effect of denosumab plus romosozumab on severe postmenopausal osteoporosis.

East Brunswick, NJ, April 23, 2025 - CRONUS PHARMA LLC, on behalf of Cronus Pharma Specialties, Hyderabad, India is issuing a ...

The total number of authentication transactions in March 2025 (246.75 crore) is higher than the transactions clocked during ...